Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects.
Clinical trial NCT04641364 · COMPLETED
Trial details
- NCT number
- NCT04641364
- Sponsor
- The First Hospital of Jilin University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2020-05-06
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.